Psoriasis
📧 Sign up to get email alerts when something new happens for Psoriasis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-06-27Clinical Trial Update: Ten-Year Biologic Drug Survival in Psoriasis: Role of Genetic and Cardiometabolic Predictors
A completed clinical study evaluating ten-year persistence of biologic therapies in psoriasis and psoriatic arthritis and how genetic and ca…
-
CLINICAL_TRIALS research · 2025-06-26Clinical Trial Update: Use of a Digital Psychotherapeutic App to Reduce Symptom Burden in Dermatology Patients [NA]
A clinical trial investigating a digital psychotherapeutic app aimed at reducing symptom burden in dermatology patients; the study is not ye…
-
CLINICAL_TRIALS trial_result · 2025-06-25Clinical Trial Update: Ustekinumab Safety and Surveillance Program Using the Ingenix NHI Database
Completed safety and surveillance study of ustekinumab using the Ingenix NHI database in psoriasis. The update summarizes safety surveillanc…
-
EMA approval · 2025-06-24EMA Authorised: Zessly (infliximab) — Sandoz GmbH
EMA authorised Zessly (infliximab) from Sandoz GmbH as a biosimilar for treatment of several inflammatory diseases, including rheumatoid art…
-
CLINICAL_TRIALS research · 2025-06-24Clinical Trial Update: Phase I Randomized, Open-label, Parallel-controlled, Pharmacokinetic and Safety Study of BR201 Injection Versus Cosentyx in Healthy Male Subjects [Phase 1]
Phase I randomized PK and safety study comparing BR201 injection to Cosentyx in healthy male subjects has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-06-24Clinical Trial Update: Evaluate the Safety and Pharmacokinetics/Pharmacodynamics and Food Effect of HS-20118 [Phase 1]
Phase 1 clinical trial evaluating the safety, pharmacokinetics/pharmacodynamics, and food effect of the investigational drug HS-20118 in pso…
-
CLINICAL_TRIALS trial_result · 2025-06-19Clinical Trial Update: Infliximab Biosimilar for Intravenous Drip Infusion 100 mg "Pfizer" Drug Use Investigation (Psoriasis)
Pfizer's infliximab biosimilar was studied in a Drug Use Investigation for psoriasis indications; the trial has completed and results were p…
-
CLINICAL_TRIALS research · 2025-06-12Clinical Trial Update: A Study to Assess Deucravacitinib Safety in Pregnancy
This clinical trial update describes an ongoing study to assess the safety of deucravacitinib in pregnant participants with psoriasis.
-
CLINICAL_TRIALS trial_result · 2025-06-12Clinical Trial Update: Anti-Inflammatory Effects of Time-Restricted Feeding
A completed clinical trial update from NHLBI examining the anti-inflammatory effects of time-restricted feeding in psoriasis and systemic in…
-
CLINICAL_TRIALS research · 2025-06-11Clinical Trial Update: Psorcast Mobile Study
The Psorcast Mobile Study sponsored by Sage Bionetworks is currently recruiting participants to study psoriatic arthritis and psoriasis.
-
CLINICAL_TRIALS trial_result · 2025-06-08Clinical Trial Update: Development and EValuation of an Online Intervention to Reduce Self-Stigma in People With Visible Chronic Skin disEases [NA]
A completed clinical trial conducted by Universitätsklinikum Hamburg-Eppendorf evaluating an online intervention to reduce self-stigma in pe…
-
CLINICAL_TRIALS trial_result · 2025-06-05Clinical Trial Update: Brain Changes in Psoriasis After Secukinumab Treatment [Phase 4]
Phase 4 trial results evaluating potential brain changes in psoriasis patients treated with secukinumab. Results were posted on 2025-06-05.
-
CLINICAL_TRIALS withdrawal · 2025-06-05Clinical Trial Update: A Pilot Study to Explore the Role of Gut Flora in Psoriasis
A pilot study sponsored by ProgenaBiome evaluating the role of gut microbiota in psoriasis has been withdrawn. The withdrawal indicates the …
-
CLINICAL_TRIALS research · 2025-06-05Clinical Trial Update: Skin Microbial Ecology in Atopic Dermatitis
This clinical trial update indicates an ongoing study at University of Rochester examining skin microbial ecology in Atopic Dermatitis and P…
-
CLINICAL_TRIALS trial_result · 2025-06-04Clinical Trial Update: A Study to Learn About the Study Medicine Called Infliximab (Genetical Recombination)[Infliximab Biosimilar 3] in People With Rheumatoid Arthritis, Ulcerative Colitis, Crohn's Disease, or Psoriasis
Pfizer-sponsored trial of infliximab biosimilar 3 in rheumatoid arthritis, ulcerative colitis, Crohn's disease, and psoriasis has completed …
-
CLINICAL_TRIALS withdrawal · 2025-05-29Clinical Trial Update: Adherence to Otezla [EARLY_Phase 1]
A clinical trial evaluating adherence to Otezla (apremilast) in psoriasis at EARLY_PHASE1 has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2025-05-25Clinical Trial Update: Mediterranean Diet vs no Dietary Intervention for Improving Signs and Symptoms of Psoriasis in Patients Treated With Anti-IL-17 or Anti-IL-23 Inhibitors [NA]
A clinical trial is evaluating whether a Mediterranean diet improves signs and symptoms of psoriasis in patients receiving anti-IL-17 or ant…
-
CLINICAL_TRIALS research · 2025-05-25Clinical Trial Update: Multi-modal Quantitative Imaging of the Skin
Clinical trial update for a multi-modal quantitative imaging study of the skin, sponsored by HJN Sverige AB/Neko Health, currently recruitin…
-
CLINICAL_TRIALS research · 2025-05-23Clinical Trial Update: A Prospective Study to Assess the Efficacy of IL-17 Inhibitors on Subclinical Enthesitis in Patients With Moderate to Severe Psoriasis Based on Power Doppler (PD) Ultrasonography (PDUS)
This clinical trial is currently recruiting to evaluate whether IL-17 inhibitors (e.g., Secukinumab) reduce subclinical enthesitis in patien…
-
CLINICAL_TRIALS research · 2025-05-22Clinical Trial Update: Evaluation of Salivary and Serum Levels of TNF-α, IL-17A, and YKL-40 in Individuals With Psoriasis
This clinical trial evaluates salivary and serum levels of inflammatory biomarkers TNF-α, IL-17A, and YKL-40 in individuals with psoriasis, …
-
CLINICAL_TRIALS research · 2025-05-21Clinical Trial Update: Sulodexide in Controlling the Recurrence of Psoriasis [Phase 3]
Phase 3 randomized trial evaluating sulodexide for preventing recurrence of psoriasis. The study is currently enrolling by invitation.
-
CLINICAL_TRIALS research · 2025-05-14Clinical Trial Update: T Cell Repertoire Analysis of Immune Mediated Skin Diseases
The document reports a completed clinical trial update analyzing T cell repertoires in immune-mediated skin diseases, focusing on psoriasis …
-
CLINICAL_TRIALS research · 2025-05-14Clinical Trial Update: Exploration of the Cellular and Molecular Mechanisms in Patients Receiving Biotherapies Targeting the IL-23/IL-17 Axis in Cutaneous Psoriasis
A clinical study in psoriasis patients explores cellular and molecular mechanisms in people treated with biotherapies targeting the IL-23/IL…
-
CLINICAL_TRIALS research · 2025-05-13Clinical Trial Update: Assessment of the Effect of a Dermatology-Oriented Spa Therapy on the Quality of Life of Patients With Psoriasis [NA]
A recruiting study evaluating a dermatology-oriented spa therapy for psoriasis. The sponsor is Thermes de Bareges.
-
CLINICAL_TRIALS research · 2025-05-13Clinical Trial Update: Effect of Semaglutide in Patients With Psoriasis and Obesity [Phase 3]
A Phase 3 clinical trial is evaluating semaglutide for patients with psoriasis and obesity and is currently recruiting.